Chitosan-Based Biomaterials for Tissue Regeneration.
Yevgeniy KimZharylkasyn ZharkinbekovKamila RaziyevaLaura TabyldiyevaKamila BerikovaDias ZhumagulKamila TemirkhanovaArman SaparovPublished in: Pharmaceutics (2023)
Chitosan is a chitin-derived biopolymer that has shown great potential for tissue regeneration and controlled drug delivery. It has numerous qualities that make it attractive for biomedical applications such as biocompatibility, low toxicity, broad-spectrum antimicrobial activity, and many others. Importantly, chitosan can be fabricated into a variety of structures including nanoparticles, scaffolds, hydrogels, and membranes, which can be tailored to deliver a desirable outcome. Composite chitosan-based biomaterials have been demonstrated to stimulate in vivo regeneration and the repair of various tissues and organs, including but not limited to, bone, cartilage, dental, skin, nerve, cardiac, and other tissues. Specifically, de novo tissue formation, resident stem cell differentiation, and extracellular matrix reconstruction were observed in multiple preclinical models of different tissue injuries upon treatment with chitosan-based formulations. Moreover, chitosan structures have been proven to be efficient carriers for medications, genes, and bioactive compounds since they can maintain the sustained release of these therapeutics. In this review, we discuss the most recently published applications of chitosan-based biomaterials for different tissue and organ regeneration as well as the delivery of various therapeutics.
Keyphrases
- drug delivery
- wound healing
- extracellular matrix
- stem cells
- cancer therapy
- hyaluronic acid
- drug release
- tissue engineering
- gene expression
- oxidative stress
- mass spectrometry
- genome wide
- randomized controlled trial
- small molecule
- patient safety
- bone regeneration
- dna methylation
- quality improvement
- cell therapy
- human health
- climate change
- postmenopausal women
- combination therapy